Amgen : Trump meets with drugmakers, seeks lower prices, U.S. production

WASHINGTON (Reuters) - U.S. President Donald Trump, in a meeting with the chief executives of several top drugmakers on Tuesday, called on the pharmaceutical industry to boost their U.S. production and lower their prices, and vowed to speed up approval times for new medicines.

Trump met with the CEOs of Novartis AG (>> Novartis AG), Merck & Co Inc (>> Merck & Co., Inc.), Johnson & Johnson (>> Johnson & Johnson), Celgene Corp (>> Celgene Corporation), Eli Lilly & Co (>> Eli Lilly and Co), Amgen Inc (>> Amgen, Inc.) as well as the head of the industry's lobbying group, the Pharmaceutical Research and Manufacturers of America.

(Reporting by Roberta Rampton and Susan Heavey)

Stocks treated in this article : Johnson & Johnson, Amgen, Inc., Celgene Corporation, Eli Lilly and Co, Merck & Co., Inc., Novartis AG